-
3 weeks ago | 
timmermanreport.com | Enhancing Agency |David Shaywitz |Luke Timmerman
The arrival of generative AI prompted many to worry about the adverse impact on human agency; after all, if the technology can effectively do what we’re doing, where does that leave us? This concern was the central focus of Reid Hoffman’s “Superagency,” which I reviewed for the WSJ earlier this year – see here. Essentially, Hoffman argues that new technologies can take some time to adjust to, but ultimately they empower us to do more things and greater things.
-
3 weeks ago | 
timmermanreport.com | Enhancing Agency |David Shaywitz |Luke Timmerman
Dying, with few exceptions, has never been especially popular, and our shared interest in not dying hardly constitutes breaking news. Nevertheless, the aspiration of living longer — and remaining healthier while doing it — appears to be all the rage. Consider these recent headlines:“Why is longevity sudden so hot?” – Chrissy Farr, Second Opinion. “The longevity business is booming – and its scientist are clashing” – Amy Dockser Marcus, The Wall Street Journal.
-
2 months ago | 
timmermanreport.com | David Shaywitz |Luke Timmerman
The likely impact of AI on health and medicine is … highly dependent on who you ask. Consider the spectacularly wide range of opinions offered in just the last several weeks. A $500 billion AI project, dubbed “Stargate,” was announced with great fanfare on January 21 in the Roosevelt room of the White House by President Trump. He was flanked by Masayoshi Son, CEO of SoftBank; Larry Ellison, chairman of Oracle; and Sam Altman, CEO of OpenAI.
-
2 months ago | 
msn.com | David Shaywitz
Continue reading More for You Continue reading More for You
-
2 months ago | 
wsj.com | David Shaywitz
How does it feel to live through the birth of a transformative technology? Historically, the experience has proved unnerving. While technologies like the printing press, the power loom, the telephone and the automobile would ultimately change the world for the better, doomsayers at the time of their first appearance focused on what could go wrong.
-
Jan 10, 2025 | 
aei.org | David Shaywitz
WE ARE LIVING THROUGH a remarkable revolution in the life sciences, with more on the way as researchers begin to juice already exceptional progress with explosive advances from artificial intelligence. Yet the actual experience of healthcare in America is often terrible—and seems to be getting worse. Our collective challenge in the United States will be productively channeling our simmering frustration.
-
Jan 10, 2025 | 
thebulwark.com | David Shaywitz
WE ARE LIVING THROUGH a remarkable revolution in the life sciences, with more on the way as researchers begin to juice already exceptional progress with explosive advances from artificial intelligence. Yet the actual experience of healthcare in America is often terrible—and seems to be getting worse. Our collective challenge in the United States will be productively channeling our simmering frustration.
-
Nov 25, 2024 | 
aei.org | David Shaywitz
As we head into Thanksgiving, I wanted to share a story that highlights the promise and possibility that can emerge from a devastating diagnosis, and emphasizes what can happen when industry, academia, and – especially — impassioned parents and dedicated advocates join forces to make a difference. Consider the devasting rare genetic disease, spinal muscular atrophy, or SMA.
-
Nov 24, 2024 | 
timmermanreport.com | David Shaywitz |Luke Timmerman
As we head into Thanksgiving, I wanted to share a story that highlights the promise and possibility that can emerge from a devastating diagnosis, and emphasizes what can happen when industry, academia, and — especially — impassioned parents and advocates join forces. Consider the devasting rare genetic disease, spinal muscular atrophy, or SMA.
-
Nov 19, 2024 | 
aei.org | David Shaywitz
“Does the crowd understand? Is it East versus WestOr man against man? Can any nation stand alone?”– Burning Heart, by Survivor – Rocky IVIn national politics, the culture wars may pit the coasts against the rest of the country. In biotech, however, the AI culture war seems to pit the coasts against each other.
